O6-benzylguanine and Carmustine in Treating Patients With Stage IA-IIA Cutaneous T-cell Lymphoma

NCT00003613 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

20

Enrollment

NIH

Sponsor class

Conditions

Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma
Stage I Cutaneous T-cell Non-Hodgkin Lymphoma
Stage II Cutaneous T-cell Non-Hodgkin Lymphoma

Interventions

DRUG: O6-benzylguanine
DRUG: carmustine
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)